The Latin America, Middle East and Africa Artificial Intelligence in Diagnostics Market is expected to witness market growth of 24.1% CAGR during the forecast period (2024-2031).
The Brazil market dominated the LAMEA Artificial Intelligence in Diagnostics Market by country in 2023, and is expected to continue to be a dominant market till 2031; thereby, achieving a market value of $126.4 million by 2031. The Argentina market is showcasing a CAGR of 25% during 2024-2031. Additionally, the UAE market would register a CAGR of 23% during 2024-2031.
AI is being utilized across various diagnostic fields, enhancing the speed and accuracy of disease detection and management. AI-powered imaging tools are revolutionizing radiology by improving image interpretation in X-rays, MRIs, CT scans, and ultrasounds. AI algorithms help detect abnormalities such as tumors, fractures, and cardiovascular diseases more accurately and efficiently. AI-powered radiology tools also reduce the workload on radiologists by automating routine image analysis and providing clinical decision support.
Moreover, AI assists in analyzing pathology slides with high precision, aiding in identifying diseases such as cancer. Digital pathology and AI enable remote diagnosis, facilitating access to expert opinions even in remote locations. AI models are trained to detect patterns in tissue samples, reducing diagnostic errors and speeding up the process. AI-driven diagnostic tools help detect cardiovascular diseases, assess heart conditions, and predict potential risks based on ECG readings and imaging studies.
In Brazil, AI spending surpassed $1 billion in 2023, reflecting a 33% year-over-year growth. The increase in Intelligent Process Automation (IPA) investments, which reached $214 million, signifies the country’s strong push toward digital transformation, including in the healthcare sector. AI-powered diagnostic solutions can benefit from this momentum, improving efficiency in medical imaging, disease detection, and patient monitoring. As AI continues to mature in Brazil, its application in diagnostics will enhance early disease detection, reduce diagnostic errors, and optimize clinical workflows, positioning AI-driven diagnostics as a critical part of the country’s healthcare evolution.
The Brazil market dominated the LAMEA Artificial Intelligence in Diagnostics Market by country in 2023, and is expected to continue to be a dominant market till 2031; thereby, achieving a market value of $126.4 million by 2031. The Argentina market is showcasing a CAGR of 25% during 2024-2031. Additionally, the UAE market would register a CAGR of 23% during 2024-2031.
AI is being utilized across various diagnostic fields, enhancing the speed and accuracy of disease detection and management. AI-powered imaging tools are revolutionizing radiology by improving image interpretation in X-rays, MRIs, CT scans, and ultrasounds. AI algorithms help detect abnormalities such as tumors, fractures, and cardiovascular diseases more accurately and efficiently. AI-powered radiology tools also reduce the workload on radiologists by automating routine image analysis and providing clinical decision support.
Moreover, AI assists in analyzing pathology slides with high precision, aiding in identifying diseases such as cancer. Digital pathology and AI enable remote diagnosis, facilitating access to expert opinions even in remote locations. AI models are trained to detect patterns in tissue samples, reducing diagnostic errors and speeding up the process. AI-driven diagnostic tools help detect cardiovascular diseases, assess heart conditions, and predict potential risks based on ECG readings and imaging studies.
In Brazil, AI spending surpassed $1 billion in 2023, reflecting a 33% year-over-year growth. The increase in Intelligent Process Automation (IPA) investments, which reached $214 million, signifies the country’s strong push toward digital transformation, including in the healthcare sector. AI-powered diagnostic solutions can benefit from this momentum, improving efficiency in medical imaging, disease detection, and patient monitoring. As AI continues to mature in Brazil, its application in diagnostics will enhance early disease detection, reduce diagnostic errors, and optimize clinical workflows, positioning AI-driven diagnostics as a critical part of the country’s healthcare evolution.
List of Key Companies Profiled
- Siemens Healthineers AG (Siemens AG)
- Zebra Technologies Corporation
- GE HealthCare Technologies, Inc.
- F.Hoffmann-La Roche Ltd.
- Microsoft Corporation
- NVIDIA Corporation
- IBM Corporation
- DeepScribe Inc.
- AliveCor, Inc.
- Digital Diagnostics, Inc. (3Derm Systems, Inc.)
Market Report Segmentation
By Component
- Software
- Hardware
- Services
By Diagnosis
- Neurology
- Radiology
- Chest & Lung
- Oncology
- Cardiology
- Pathology
- Other Diagnosis
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Competition Analysis - Global
Chapter 5. LAMEA Artificial Intelligence in Diagnostics Market by Component
Chapter 6. LAMEA Artificial Intelligence in Diagnostics Market by Diagnosis
Chapter 7. LAMEA Artificial Intelligence in Diagnostics Market by Country
Chapter 8. Company Profiles
Companies Mentioned
- Siemens Healthineers AG (Siemens AG)
- Zebra Technologies Corporation
- GE HealthCare Technologies, Inc.
- F. Hoffmann-La Roche Ltd.
- Microsoft Corporation
- NVIDIA Corporation
- IBM Corporation
- DeepScribe Inc.
- AliveCor, Inc.
- Digital Diagnostics, Inc. (3Derm Systems, Inc.)
Methodology
LOADING...
